Jazz Pharmaceuticals (JAZZ) Asset Utilization Ratio (2011 - 2026)

Jazz Pharmaceuticals' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.38 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 9.33% year-over-year to 0.38 in Q1 2026; TTM through Mar 2026 was 0.38, a 9.33% increase from a year earlier, with the FY2025 full-year figure at 0.36, up 3.7% from the prior year.
• Asset Utilization Ratio grew to 0.38 in Q1 2026 per JAZZ's latest filing, from 0.37 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.38 in Q1 2026 and bottomed at 0.27 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.34 (2023), against an average of 0.34.
• Biggest YoY gain for Asset Utilization Ratio was 49.0% in 2022; the steepest drop was 25.19% in 2022.
• Year by year, Asset Utilization Ratio stood at 0.34 in 2022, then retreated by 1.61% to 0.34 in 2023, then decreased by 1.18% to 0.34 in 2024, then advanced by 10.59% to 0.37 in 2025, then increased by 1.78% to 0.38 in 2026.
• Per Business Quant, the three latest JAZZ Asset Utilization Ratio figures stand at 0.38 (Q1 2026), 0.37 (Q4 2025), and 0.37 (Q3 2025).